Zman, you are spot on.
EBITDA is the most important factor considering the industry but PBT cannot be ignored. Current normalised PBT of $5.2m is rather low considering their debt level. They have 70 clinics - thats $75K per clinic. Rather low for radiology. Some of them must be running at a loss considering that their recent acquisition(s) had mostly larger sites.
The share price reduced from 1.12 to 0.15 and the CEO is receiving 15m options with a strike price of 50% premium to the current level? Does that sound like a reasonable KPI? What about minimum profit levels or at least revenue targets?
The debt is concerning. In particular if they are looking at a further $50m unsecured facility.
I am still not sure about the direct and short-mid term benefit of the $10m Enlitic or the sport sponsorship. That is a lot of money for a company with a market cap of $80m.
Zman, you are spot on. EBITDA is the most important factor...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CAJ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
-0.005(1.32%) |
Mkt cap ! $399.8M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 38.5¢ | 37.5¢ | $454.7K | 1.204M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 284881 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 126553 | 7 |
View Market Depth
| Last trade - 13.04pm 15/10/2024 (20 minute delay) ? |
| CAJ (ASX) Chart |